Early Warning -
Early Action

IscAlert™ is a miniaturized disposable
biosensor that provides early
warning of ischemia.

A lifesaver Biomarker

Carbon dioxide (CO2) is an end-metabolic product of all cells in all tissues. The human body keeps the tissue levels of CO2 in a narrow and very well controlled range. Any change of the tissue CO2 (or) level is considered pathologic, indicating either insufficient blood or oxygen to the tissue (ischemia), or excess oxygen to the tissue (hyperventilation).

The Unique Sensor Technology

SensoCure is the owner of a unique proprietary technology for detecting the tissue pCO2 level. The tissue pCO2 level may change due to critical perfusion, respiration or metabolic conditions. The SensoCure pCO2 technology gives basis for a row of products for early detection of either critical local or systemic conditions with high mortality and considerable cost to the health care providers.

The Product

IscAlert ™ offers a numbers of benefits


IscAlert™ addresses a largely unmet medical need as a user friendly, fast, robust real time monitoring device of ischemia.


IscAlert™ fits well into current medical practice by giving improved patient outcome and therefore substantially reduces healthcare costs by lowering the need for e.g. intensive care.


IscAlert™ is a direct and realtime method for measuring Ischemia.

Sensocure AS

Sensocure AS develops biomedical
sensors for healthcare. The main product
under development is IscAlert™, a CO2
sensor designed for the earliest possible
detection of ischemia.

Press and public relations

Funding from Innovation Norway

We have received funding from Innovation Norway for optimalization of our calibration method. In this project we will develop a one-stop-calibration method which is fast, robust and user friendly. The project period for project KALISC II will be from 2020-2023.

Sensocure er Gasellebedrift

Sensocure er en av de 3484 norske bedrifter som kan kalle seg for Gaselle-bedrift 2019. For å komme på DNs gaselleliste, må bedriften de siste fire årene ha:- hatt omsetning over én million kroner- levert godkjente regnskaper- minst doblet omsetningen- hatt positivt...

Sensocure blant Norges raskest voksende

Deloitte Norges Technology Fast 50 er en rangering av Norges 50 raskest voksende teknologiselskaper, basert på omsetningsvekst gjennom de siste fire årene. Vi er stolte av å være på den endelige listen over Fast 50 for 2019! Les mer om Fast 50